INS and metabolic dysfunction-associated steatotic liver disease: (2011) identified in mice miR‐103 and ‐107 as species upregulated in NAFLD liver, confirmed this result in a human cohort, and provided evidence for roles of these miRNAs as negative regulators of insulin sensitivity.